RecruitingUterine FibroidsLeiomyomaMenstrual Pain
An Open-Label Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Symptoms
Eligible age
20–45 yrs
Accepts
Women
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This is a 24-week, single-arm, open-label, virtual study evaluating the effects of Elix Cycle Balance and Elix Daily Harmony on uterine fibroid-related symptoms and quality of life in 42 participants. Participants will self-administer the investigational herbal supplements daily and complete validated questionnaires at scheduled timepoints to assess symptom severity and quality of life.
Sponsor: Zenchi, Inc.
You may qualify if…
- ✓ Be female.
- ✓ Be aged 20-45.
- ✓ BMI 18.5 - 24.9 kg/m2
- ✓ Self-reported prior diagnosis of uterine fibroids.
- ✓ Anyone who is generally healthy - does not live with any uncontrolled chronic disease.
- ✓ Self-reported moderate to severe discomfort during menstruation, related to pelvic cramps, bloating, mood swings, or fatigue.
- ✓ Self-reported menstrual cramps during their cycle, for the past six months minimum.
- ✓ If taking hormonal birth control, has been doing so consistently for at least three months, and experiences a menstrual cycle with a period.
You may not qualify if…
- ✕ Does not experience a regular menstrual cycle (21-35 days).
- ✕ Does not experience menstrual cramping.
- ✕ Follows an extreme diet intervention such as dry fasts, water fasts, or ketogenic diets.
- ✕ Anyone who has experienced significant weight loss in the past three months prior to study participation.
- ✕ Unwilling to stop the use of any medication or herbal remedies/supplements that can affect the menstrual cycle.
- ✕ Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders.
- ✕ Anyone with known severe allergic reactions.
- ✕ Anyone with any allergies or sensitivities to any of the study product ingredients.
Where it's recruiting
Nevada
Las Vegas
Source: ClinicalTrials.gov · NCT07078682 · last updated 2025-09-12